HCV: Highlighs from EASL 2013

This activity was developed by gastroenterologists and hepatologists and other healthcare providers managing patients with heptatitis C

Learning Objectives

  • Identify the most important baseline characteristics to consider when assessing benefit/risk for each individual patient in order to make best decision to treat or wait;
  • Identify the next way of treatment regimens likely to be approved and understand in which patient subtypes they have been studied;
  • Discuss the treatment regimens likely to be approved in the near/midterm and describe the patient populations for which these regimens are likely to be approved
Course summary
Registration Opens: 
12/02/2014
Registration Expires: 
12/31/2014

Available Credit

Accreditation Period

Registration Opens: 
12/02/2014
Registration Expires: 
12/31/2014
Please login or register to take this course.